Finance

Lists
Q3 2026 earnings • released • EPS miss -52.38% • Revenue miss -5.38%
See results
NUS:NYSE
NU Skin Enterprises Inc
$4.10
-9.29%
(-0.42) 1D
Nov 6, 4:00:05 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NUS...
Open
$4.31
High
$4.61
Low
$4.09
Mkt. cap
199.57M
Avg. vol.
464.23K
Volume
896.34K
Dividend
5.85%
Quarterly dividend
$0.06
Ex-dividend date
Aug 28, 2026
52-wk high
$11.67
52-wk low
$4.09
EPS
-$4.48
Beta
0.92
Shares outstanding
48.68M
No. of employees
3K
Open
$4.31
High
$4.61
Low
$4.09
Mkt. cap
199.57M
Avg. vol.
464.23K
Volume
896.34K
Dividend
5.85%
Quarterly dividend
$0.06
Ex-dividend date
Aug 28, 2026
52-wk high
$11.67
52-wk low
$4.09
EPS
-$4.48
Beta
0.92
Shares outstanding
48.68M
No. of employees
3K
News stories
From web sources and news partners
Profile
Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors. The company was founded in 1984 by Blake Roney, Nedra Roney, Sandie Tillotson, and Steven J. Lund. Wikipedia
About NU Skin Enterprises Inc
CEORyan Napierski
Employees2.8K
Founded1984
HeadquartersProvo, Utah, United States
SectorConsumer Staples
IndustryPersonal care products
Websitenuskin.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Last report
Nov 6, 2026
Fiscal period
Q3 2026
$0.10 / $0.21
-52.38%miss
Revenue / Est. (USD)
311.01M / 328.70M
-5.38%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
364.21M
370.32M
320.61M
320.11M
Cost of goods sold
107.49M
108.34M
106.14M
101.79M
Cost of revenue
107.49M
108.34M
106.14M
101.79M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
235.08M
238.74M
208.60M
198.77M
Operating expense
235.08M
238.74M
208.60M
198.77M
Total operating expenses
342.57M
347.08M
314.74M
300.56M
Operating income
21.64M
23.24M
5.86M
19.56M
Other non operating income
26.57M
-29.14M
2.82M
-534.00K
EBT including unusual items
15.99M
18.19M
2.60M
-63.18M
EBT excluding unusual items
44.07M
-9.89M
4.44M
15.70M
Income tax expense
-1.08M
3.70M
763.00K
186.62M
Effective tax rate
-6.78%
20.34%
29.36%
-295.41%
Other operating expenses
-
-
-
-
Net income
17.08M
14.49M
1.84M
-249.80M
Net profit margin
4.69%
3.91%
0.57%
-78.03%
Earnings per share
0.34
0.29
0.14
0.20
Interest and investment income
-
-
-
-
Interest expense
-4.14M
-3.99M
-4.25M
-3.32M
Net interest expenses
-4.14M
-3.99M
-4.25M
-3.32M
Depreciation and amortization charges
-
-
-
-
EBITDA
33.73M
36.16M
18.21M
32.21M
Gain or loss from assets sale
243.00K
-11.00K
303.00K
-10.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps